Table 1 Characteristics and demographic data of subjects
Characteristic (n = 17) | Value | Range |
|---|---|---|
Age (years) | 62.7 ± 10.4 | 41.0–78.0 |
Sex, n (%) | ||
 Male | 9 (52.9 %) |  |
 Female | 8 (47.1 %) |  |
Height (cm) | 169.5 ± 6.6 | 160.0–183.0 |
Body mass (kg) | 72.3 ± 10.0 | 57.5–90.0 |
Body mass index (kg/m2) | 25.2 ± 3.2 | 20.2–33.1 |
Type of stroke, n (%) | ||
 Ischaemic | 15 (88.2 %) |  |
 Haemorrhagic | 2 (11.8 %) |  |
Hemiparetic side, n (%) | ||
 Left | 7 (41.2 %) |  |
 Right | 10 (58.8 %) |  |
Stage, n (%) | ||
 Sub-acute | 6 (35.3 %) |  |
 Chronic | 11 (64.7 %) |  |
Days post stroke, | 485.3 (535.5) | 21–1810 |
 median (IQR) | 350 (788) |  |
FAC | 3.6 ± 2.1 | 0–5 |
NIHSS | 3.1 ± 3.2 | 0–11 |
MMSE score | 28.1 ± 2.3 | 21–30 |
Modified Rankin Scale | ||
 0–2 | 12 (70.6 %) |  |
 3 | 1 (5.9 %) |  |
 4–5 | 4 (23.5 %) |  |
Comorbidities, n (%) | ||
 Hypertension | 9 (52.9 %) |  |
 Diabetes mellitus | 1 (5.9 %) |  |
 Dyslipidemia | 4 (23.5 %) |  |
 None | 4 (23.5 %) |  |
Antihypertensive medications, n (%) | ||
 β-blocker | 2 (11.9 %) |  |
 ACE inhibitors | 3 (17.6 %) |  |
 Calcium channel blockers | 3 (17.6 %) |  |
 None | 9 (52.9 %) |  |